Participants were examined using 2 US systems: LOGIQ S8 (software version R2, revision 1.1, with GE Healthcare, Waukesha, WI; L6-15MHz) and Mylab 70 XVG (version EVO 13.60M; Esaote SpA, Genoa, Italy; LA523, L4-13MHz). Body fat percentage (%) was calculated by scales based method using a Tanita Body composition analyser, TBF-300MA. Leg circumference was measured in centimetre (cm) using a standard measurement tape, at the level of mid-pole patella. Redcap [25] , a data capture application, was employed to record data on participant physical and body composition characteristics including height, weight, BMI, body fat %, leg circumference and self-reported physical activity levels (using the International Physical Activity Questionnaire (IPAQ) long form, and scored as high, moderate and low physical activity level) [26] .
Mylab 70 xvg
Manufactured by Esaote
Sourced in Italy
The MyLab 70 XVG is a diagnostic ultrasound system designed for general imaging applications. It features a high-resolution display, advanced imaging capabilities, and intuitive user interface.
Automatically generated - may contain errors
Lab products found in correlation
Mylab 90, by Mindray (3 mentions)
Mylab classic c, by Esaote (3 mentions)
Aplio 400, by GE Healthcare (2 mentions)
Logiq s8, by GE Healthcare (1 mentions)
Selenia dimension, by Hologic (1 mentions)
Mylab one, by Esaote (1 mentions)
Sonovue, by Bracco (1 mentions)
Mylab twice scanner, by Esaote (1 mentions)
Aplio xg, by Esaote (1 mentions)
Acuson sequoia, by Siemens (1 mentions)
Logiq e9, by Siemens (1 mentions)
Epiq 5, by Philips (1 mentions)
Logiq e9, by GE Healthcare (1 mentions)
17 protocols using mylab 70 xvg
1
Comprehensive Body Composition Assessment
2
Multimodal Breast Imaging Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Radiological assessment included a bilateral two-projection 2D-3D mammography (MMG) (Selenia® Dimensions®, Hologic®, Bedford, USA) and ultrasonographic (US) examinations were performed using a 10–13 MHz transducer and a US unit (ESAOTE, MyLab 70 XVG, Genoa, Italy).
3
Assessing Non-Alcoholic Fatty Liver Disease
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
NAFLD was assessed by liver ultrasound (LUS) (Esaote MyLab70 XVG device and the Convex 5-MHz probe) at baseline and then quarterly until the end of the project. A scoring system was adopted to obtain a semi-quantitative evaluation of the liver fat, based on three parameters: (1) contrast between liver and kidney parenchyma; (2) deep penetration of the ultrasound beam, and (3) sharpness of vascular structures, especially veins. Items were scored 0 to 2 [19 ,20 (link),21 (link)].
NAFLD was then categorized as absent (0), mild (1–2), moderate (3–4), and severe (5–6). Liver size, margins, and echo-structure were assessed during the examination.
Laboratory measurements included triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose, alanine transaminase (ALT), aspartate transaminase (AST), gamma glutamyl transferase (GGT), insulin, and glycosylated hemoglobin (Hb1Ac). As with LUS, biochemical assessments were performed at baseline and every trimester until month 12. In this work, only LUS and some biochemical markers were used in the analyses.
NAFLD was then categorized as absent (0), mild (1–2), moderate (3–4), and severe (5–6). Liver size, margins, and echo-structure were assessed during the examination.
Laboratory measurements included triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose, alanine transaminase (ALT), aspartate transaminase (AST), gamma glutamyl transferase (GGT), insulin, and glycosylated hemoglobin (Hb1Ac). As with LUS, biochemical assessments were performed at baseline and every trimester until month 12. In this work, only LUS and some biochemical markers were used in the analyses.
4
Echocardiography in Anesthetized Mice
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Echocardiography was blindly performed at 12 months with the MyLab70 XVG device (Esaote, Indianapolis, IN) using a linear 18MHhz transducer. Probe selection and frequency, depth of field, overall gain, time-gain compensation, and focal zone were adjusted at the discretion of the sonographer to optimize image quality. Examination was performed on 2% isoflurane-anaesthetized mice. Measurements were realized after stabilization of the cardiac frequency between 350 and 380 beats/min. Images of the short axis were obtained in M-Mode. Left ventricular diameters were measured at end of diastole and end of systole as well as thickness of left ventricular posterior wall and interventricular septum in diastole.
5
Standardized Ultrasound Lesion Assessment
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
All HF-US examinations in our series were performed with an Esaote MyLab 70 XVG (Genoa, Italy), using a 18 MHz linear probe, at times integrated by a 13 MHz with specific setting. In selected cases, for very small and superficial lesions, an Esaote MyLab One with 22 MHz linear probe was utilized. Colour-Doppler US was performed with multiple samplings from different areas of the lesion thus allowing assessment of slow-flow conditions. The following lesions characteristics were reported: size, echogenicity, structure, margins, possible internal necrosis and their depth, besides vascularization pattern (1 = no vascularization, 2 = perilesional vascularization and 3 = intralesional vascularization). On the basis of these parameters, an overall numerical value was attributed to suspicious lesions between 0 and 3 (0 = benign lesion, 1 = possibly benign lesion, 2 = probably malignant lesion and 3 = malignant lesion) [18 (link)-20 (link)].
6
Contrast-Enhanced Ultrasound (CEUS) for Liver Lesion Assessment
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
CEUS was always preceded by a careful US survey, assessing the size and appearance of the lesion/s. This baseline assessment was done to appropriately choose the liver area or areas to be particularly focused in the forthcoming contrast-enhanced part of the US study. In all cases, a separated injection was performed for each liver lobe. For both injections, the arterial phase assessment was focused on any known lesion at baseline US. CEUS was performed as a low- mechanical index, double-split mode, real-time modality. We employed a Technos MyLab 70 XVG and MyLab Twice scanner (Esaote, Genoa, Italy), injecting 2.4 ml of a sulfur hexafluoride-based contrast medium (SonoVue, Bracco, Milan, Italy) per each liver lobe. After the injection, the radiologist focused the sonographic field of view on the parenchymal area of interest, waiting for the microbubble’s arrival. Thereafter, he/she moved the transducer to explore the remaining parenchyma of each lobe, with special reference to the resected area.
7
Semiquantitative Ultrasound Evaluation of Joints
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Thirty joints were examined by ultrasonography for each patient (wrists, MCP 1–5, PIP 1–5, DIP 2–5) at three different time points (week 0, 12 and 24). Evaluation was done semiquantitatively (grades 0–3) for synovial thickening, joint effusions in GSUS and hyperperfusion in PDUS according to Manggi-Manzoni et al. [15 (link)]. Joints graded 1–3 were scored as active in the respective examination mode [10 (link)]. Ultrasonography examination was performed using LOGIQ e notebook with 12-MHz linear transducer by General Electrics Healthcare, Toshiba Aplio XG and MyLab70 XVG Esaote.
8
Ultrasound Characterization of Thyroid Nodules
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The following five ultrasonic scanners were used in the present study: Esaote MyLab 70 XVG (Genova, Italy), Esaote MyLab Classic C (Genova, Italy), Esaote Mylab 90 (Genova, Italy), mindray (Shenzhen, China) and Hitachi (Tokyo, Japan). The 5–10 MHz broadband linear array probes were used and the central frequency was 7.5 MHz. The positions and scanning areas of all patients were the same during the scanning process. In brief, the patients were placed in the supine position with the neck dorsal stretched as much as possible to sufficiently expose the anterior neck region. Scanning was performed on the transverse, longitudinal and oblique sections, and the nodule data, including number, size, shape, boundary, halo around the boundary, internal echogenicity, calcification, internal and peripheral blood flow, and bilateral neck lymph nodes, were recorded.
9
Carotid and Femoral Artery IMT Evaluation
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
All subjects underwent ultrasonographic evaluation of peripheral arteries by B mode using ESAOTE MyLab 70XVG and linear tranducer of 7.5 MHz. Intima media thickness (IMT) of a common carotic artery (CCA) and common femoral artery (FCA) bilaterally were measured. Measurements were performed under standard condition in longitudinal projection. Four measurements were realized on each side and mean IMT on the right and left CCA and FCA were calculated. An average value of both right and left sides represented a fi nal result of IMT. Value of 0.9 mm or more has been considered pathologic.
10
Ultrasound Imaging of Cervical Lesions
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The following six models of ultrasonic diagnostic scanners were used in medical center A: MyLab 70 XVG (Genova, Italy), Esaote MyLab Classic C (Genova, Italy), Esaote MyLab 90 (Genova, Italy), Mindray (Shenzhen, China), Hitachi (Tokyo, Japan), and Philips EPIQ 5 (Washington, USA). The following four models of ultrasonic diagnostic scanners were used in medical center B: Toshiba Aplio 400 (Tochigi, Japan), GE Logiq E9 (Wauwatosa, USA), Siemens Acuson Sequoia (Auburn Hills, USA), and SonoScape S60 VO (Shenzhen, China). In this study, 5–10 MHz broadband linear array probes were used, with the central frequency being 7.5 MHz.
All patients were in the supine position, with their necks fully extended to the far back so that the anterior cervical area was fully exposed. Ultrasonic scanning of lesions was performed in transverse sections, longitudinal sections, and other sections. The number of nodules and their size, shape, boundary, surrounding acoustic halo, internal echo, calcification, and internal and peripheral blood supply as well as the bilateral neck lymph nodes were recorded.
All patients were in the supine position, with their necks fully extended to the far back so that the anterior cervical area was fully exposed. Ultrasonic scanning of lesions was performed in transverse sections, longitudinal sections, and other sections. The number of nodules and their size, shape, boundary, surrounding acoustic halo, internal echo, calcification, and internal and peripheral blood supply as well as the bilateral neck lymph nodes were recorded.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!